Recently, Masamha et al. [153] find that CFIm25 plays a carcinogenic role in gliomas, and knockdown of CFIm25 decreases the expression of terminal polyadenylation of cyclin D1 (CCND1) and increases the proliferation of tumor cells. Here, NUDT21 is linked to central nervous system cancer.